# Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

> **NCT07385131** · — · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 300 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- CD - Crohn's Disease
- UC - Ulcerative Colitis

## Interventions

- **DRUG:** Dexamethasone (IV)

## Key facts

- **NCT ID:** NCT07385131
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385131, "Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07385131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*